Why the study?
Does nitric oxide improve hemodynamics in a patient with pulmonary hypertension and mitral valve insufficiency undergoing a portosystemic shunt?
Case Report (n=1)
Does nitric oxide improve hemodynamics in a patient with pulmonary hypertension and mitral valve insufficiency undergoing a portosystemic shunt?
Answers are grounded in this paper and cite their sources.
Nitric oxide successfully managed intraoperative pulmonary hypertension and improved hemodynamics in a patient with portal hypertension and mitral valve insufficiency undergoing a portosystemic shunt.
We report the successful management of intraoperative pulmonary hypertension in a patient with mitral valve insufficiency and portal hypertension. A 48-year-old male with portal hypertension presented for a portosystemic shunt. Previously undiagnosed mitral valve insufficiency and pulmonary hypertension complicated his anaesthetic management. His intraoperative course was marked by systolic hypotension, pulmonary hypertension and a reduction in cardiac output. The use of nitric oxide in this patient reduced right ventricular afterload, increased cardiac output, without exacerbating pre-existing systolic hypotension.
No takes yet. Share an insight, caveat, or question.
Kinirons et al. (1999) conducted a case report in intraoperative pulmonary hypertension, mitral valve insufficiency, and portal hypertension (n=1). nitric oxide was evaluated on right ventricular afterload, cardiac output, and systolic hypotension.
Synapse has enriched 10 related papers. Consider them for comparative context: